Laboratory Corporation of America (NYSE:LH) announced that it received FDA emergency use authorization (EUA) for its COVID-19 test home collection kit.
Burlington, N.C.-based LabCorp’s Pixel by LabCorp COVID-19 test home collection kit’s EUA makes it the first test kit available over the counter without requiring a prescription, enabling LabCorp to potentially distribute the kit through retail channels, according to a news release.
Upon purchase, users register their Pixel by LabCorp COVID-19 test collection kit on the Pixel by LabCorp website. Test results are securely delivered to the user via the online portal and, if a result comes back positive, a healthcare provider is available to counsel consumers with treatment and actions.
The Pixel by LabCorp COVID-19 at-home collection kit is not a substitute for visits to a healthcare professional, the company said, and is for use by adults age 18 and older.
“With the first over-the-counter at-home collection kit ever authorized by the FDA for COVID-19, we are empowering people to learn about their health and make confident decisions,” LabCorp president & chief medical officer Dr. Brian Caveney said in the release. “With this authorization, we can help more people get tested, reduce the spread of the virus and improve the health of our communities.”
